TrialLancet (London, England)2019

Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial.

Andreas Stahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.